Your browser doesn't support javascript.
loading
Psychometric properties of the Dependence Scale in large randomized clinical trials of patients with mild and moderate Alzheimer's disease.
Wyrwich, Kathleen W; Auguste, Priscilla; Buchanan, Jacqui; Rudell, Katja; Lacey, Loretto; Leibman, Christopher; Symonds, Tara; Brashear, H Robert.
Afiliación
  • Wyrwich KW; Evidera (formerly United BioSource Corporation), Bethesda, MD, USA kathy.wyrwich@evidera.com.
  • Auguste P; Evidera (formerly United BioSource Corporation), Bethesda, MD, USA.
  • Buchanan J; Janssen Alzheimer Immunotherapy, San Francisco, CA, USA.
  • Rudell K; Pfizer Patient-Reported Outcomes Centre of Excellence, Surrey, United Kingdom.
  • Lacey L; Janssen Alzheimer Immunotherapy, San Francisco, CA, USA.
  • Leibman C; Janssen Alzheimer Immunotherapy, San Francisco, CA, USA.
  • Symonds T; Pfizer Patient-Reported Outcomes Centre of Excellence, Surrey, United Kingdom.
  • Brashear HR; Janssen Alzheimer Immunotherapy, San Francisco, CA, USA.
Am J Alzheimers Dis Other Demen ; 29(7): 620-9, 2014 Nov.
Article en En | MEDLINE | ID: mdl-24736801
OBJECTIVE: The need for assistance from others is a hallmark concern in Alzheimer's disease (AD). The psychometric properties of the Dependence Scale (DS) for measuring treatment benefit were investigated in large randomized clinical trials of patients with mild to moderate AD. METHODS: Reliability, validity, and responsiveness of the DS were examined. Path models appraised relationships and distinctiveness of key AD measures. The responder definition was empirically derived. RESULTS: Generally acceptable reliability (α ≥ .65), significant (P < .001) known-groups tests, and moderate to strong correlations (r ≥ .31) confirmed the DS psychometric properties. Path models supported relationships and distinctiveness of key AD measures. A DS change of ≤ 1 point for patients with limited home care and ≤ 2 points for patients with assisted living care best described stability of the level of dependence on caregivers. CONCLUSION: The DS is a psychometrically robust measure in mild to moderate AD. The empirically derived responder definition aids in the interpretation of DS change.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psicometría / Actividades Cotidianas / Evaluación de la Discapacidad / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Alzheimers Dis Other Demen Asunto de la revista: NEUROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psicometría / Actividades Cotidianas / Evaluación de la Discapacidad / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Alzheimers Dis Other Demen Asunto de la revista: NEUROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos